NanoVibronix, Inc. (NAOV) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for NanoVibronix, Inc. (NAOV:NASDAQ), powered by AI.

Current Price
$0.86
P/E Ratio
-0.0
Market Cap
23,204
Sector
Healthcare
What is the NanoVibronix, Inc. stock price forecast?

NanoVibronix, Inc. is currently trading at $0.86. View real-time AI analysis on Alpha Lenz.

What is NanoVibronix, Inc. insider trading activity?

View the latest insider trading data for NanoVibronix, Inc. on Alpha Lenz.

What is NanoVibronix, Inc.'s P/E ratio?

NanoVibronix, Inc.'s P/E ratio is -0.0.

NanoVibronix, Inc.

NASDAQ · NAOV
$0.86-0.05(-4.98%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about NanoVibronix, Inc.'s future dividend policy...
Alpha Chat Insight

NanoVibronix, Inc. trades at a P/E of -0.0 (undervalued) with modest ROE of -160.6%. 3Y revenue CAGR of 14.7% highlights clear growth momentum.

Ask for details

Company Overview

NanoVibronix, Inc. is a healthcare equipment company specializing in the design, development, and marketing of medical devices that utilize proprietary low-intensity surface acoustic wave (SAW) technology. Its main focus is on non-invasive biological response-activating devices aimed at addressing key medical needs, particularly in pain therapy, biofilm prevention in medical catheters, and wound healing. Notable products include PainShield, a wearable patch delivering low-frequency ultrasound for drug-free pain management, and UroShield, an ultrasound actuator that attaches to catheters to reduce bacterial biofilm formation and lower the risk of catheter-associated infections. The company also has pipeline products targeting wound healing and potentially other therapeutic applications, all leveraging the core SAW platform. NanoVibronix outsources its manufacturing, while prioritizing research, regulatory compliance, and the development of distributor partnerships to expand its market reach. Established in 2003 and based in Texas, NanoVibronix serves hospitals, long-term care facilities, pain clinics, and individual patients worldwide, playing a significant role in advancing non-invasive therapies in the healthcare sector.

CEODr. Doron Robert Besser M.D.
SectorHealthcare
IndustryMedical Devices
Employees31

Company Statistics

FY 2024

Profile

$23.20KMarket Cap
$2.56MRevenue
0.00Shares Out
31Employees

Margins

58.95%Gross
-138.78%EBITDA
-140.03%Operating
-144.10%Pre-Tax
-144.84%Net

Valuation

-0.01P/E
0.04P/B
0.01EV/Sales
0.17EV/EBITDA
-0.01P/FCF

Growth (CAGR)

14.70%Rev 3Yr
37.00%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-71.92%ROA
-160.56%ROE
-68.93%ROIC

Financial Health

$752.00KCash & Cash Equivalents
$2.25MNet Debt
478.79%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

NanoVibronix, Inc. (ticker: NAOV) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 31 employees. Market cap is $23,204.

The current price is $0.86 with a P/E ratio of -0.01x and P/B of 0.04x.

ROE is -160.56% and operating margin is -140.03%. Annual revenue is $3M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
NanoVibronix, Inc. (NAOV) Stock Forecast 2026 $0.86 — Price, Financials & Analyst Targets | Alpha Lenz